Sandra Forman

2018 Guidelines for the Early Management of Patients With Acute Ischemic Stroke: A Guideline for Healthcare Professionals From the American Heart Association/American Stroke Association

Targeting of HIF-α to the von Hippel-Lindau Ubiquitylation Complex by O ₂ -Regulated Prolyl Hydroxylation

A unique mechanism of β-blocker action: Carvedilol stimulates β-arrestin signaling

A Conserved Family of Prolyl-4-Hydroxylases That Modify HIF

Global cancer statistics 2018: GLOBOCAN estimates of incidence and mortality worldwide for 36 cancers in 185 countries

Global Cancer Statistics 2020: GLOBOCAN Estimates of Incidence and Mortality Worldwide for 36 Cancers in 185 Countries

ACC/AHA 2007 Guidelines for the Management of Patients With Unstable Angina/Non–ST-Elevation Myocardial Infarction

Safety and Cost-Effectiveness of Early Discharge After Primary Angioplasty in Low Risk Patients With Acute Myocardial Infarction 11Research funding for this study was provided by unrestricted grants from Advanced Cardiovascular Systems, Santa Clara, California; Mallinckrodt Medical, Inc., Saint Louis, Missouri; Datascope Corporation, Montvale, New Jersey; St. Jude Medical, Chelmsford, Massachusetts; and Siemens Corporation, Iselin, New Jersey.

Intracranial hemorrhage in association with thrombolytic therapy: Incidence and clinical predictive factors

Short-Term Effects of Nose-Only Cigarette Smoke Exposure on Glutathione Redox Homeostasis, Cytochrome P450 1A1/2 and Respiratory Enzyme Activities in Mice Tissues

Effects of Percutaneous Coronary Interventions in Silent Ischemia After Myocardial Infarction

Ischemic stroke and intracranial hemorrhage following thrombolytic therapy for acute myocardial infarction: A risk-benefit analysis

Effect of Beta Blockers, Particularly Carvedilol, on Reducing the Risk of Events After Acute Myocardial Infarction

Surviving ischemia: adaptive responses mediated by hypoxia-inducible factor 1

C. elegans EGL-9 and Mammalian Homologs Define a Family of Dioxygenases that Regulate HIF by Prolyl Hydroxylation

2011 ACCF/AHA/SCAI Guideline for Percutaneous Coronary Intervention

The Risk of Stroke in Patients with Acute Myocardial Infarction after Thrombolytic and Antithrombotic Treatment

Blood pressure during the first minutes of focal cerebral ischemia

Prospects for Cardiovascular Research

Treatment of no-reflow in degenerated saphenous vein graft interventions: Comparison of intracoronary verapamil and nitroglycerin

The Seventh Report of the Joint National Committee on Prevention, Detection, Evaluation, and Treatment of High Blood Pressure<SUBTITLE>The JNC 7 Report</SUBTITLE>

Exercise Standards for Testing and Training

Ten-Year Mortality from Cardiovascular Disease in Relation to Cholesterol Level among Men with and without Preexisting Cardiovascular Disease

Exercise training following myocardial infarction improves myocardial perfusion assessed by thallium-201 scintigraphy

Value and Limitations of Chest Pain History in the Evaluation of Patients With Suspected Acute Coronary Syndromes

Deletion polymorphism in the gene for angiotensin-converting enzyme is a potent risk factor for myocardial infarction

HIF-1, O2, and the 3 PHDs

Influence of Diabetes Mellitus on Clinical Outcome in the Thrombolytic Era of Acute Myocardial Infarction fn1fn1The GUSTO-I study was supported by a combined grant from Bayer, New York, New York; CIBA-Corning, Medfield, Massachusetts; Genetech, South San Francisco, California; ICI Pharmaceuticals, Wilmington, Delaware; and Sanofi Pharmaceuticals, Paris, France.

Stepwise Selection in Small Data Sets A Simulation Study of Bias in Logistic Regression Analysis

Neurosurgical evacuation of intracranial hemorrhage after thrombolytic therapy for acute myocardial infarction: Experience from the GUSTO-I Trial

Angiographic assessment of the infarct-related residual coronary stenosis after spontaneous or therapeutic thrombolysis

Percutaneous Coronary Intervention of Functionally Nonsignificant Stenosis

Fractional Flow Reserve versus Angiography for Guiding Percutaneous Coronary Intervention

Surgical bleeding: unexpected effect of a calcium antagonist

Early and long-term clinical outcomes associated with reinfarction following fibrinolytic administration in the thrombolysis in myocardial infarction trials

Acute Stressors and Cortisol Responses: A Theoretical Integration and Synthesis of Laboratory Research.

Measuring inconsistency in meta-analyses

Angiographic Versus Functional Severity of Coronary Artery Stenoses in the FAME Study

Effects of Atorvastatin on Early Recurrent Ischemic Events in Acute Coronary Syndromes<SUBTITLE>The MIRACL Study: A Randomized Controlled Trial</SUBTITLE>

Percutaneous transluminal coronary angioplasty versus medical treatment for non-acute coronary heart disease: meta-analysis of randomised controlled trials

Effect of age on use of thrombolytic therapy and mortality in acute myocardial infarction

Intravenous nicorandil can preserve microvascular integrity and myocardial viability in patients with reperfused anterior wall myocardial infarction

Evaluation of B-type natriuretic peptide for risk assessment in unstable Angina/Non–ST-elevation myocardial infarction

Apical ballooning syndrome (Tako-Tsubo or stress cardiomyopathy): A mimic of acute myocardial infarction

The Pathogenesis of Coronary Artery Disease and the Acute Coronary Syndromes

Predictors of major bleeding in acute coronary syndromes: the Global Registry of Acute Coronary Events (GRACE)

A simple risk index for rapid initial triage of patients with ST-elevation myocardial infarction: an InTIME II substudy

Outcomes of Patients With Acute Coronary Syndrome and Previous Coronary Artery Bypass Grafting (from the Pravastatin or Atorvastatin Evaluation and Infection Therapy [PROVE IT-TIMI 22] and the Aggrastat to Zocor [A to Z] Trials)

Particulate and vapor phase constituents of cigarette mainstream smoke and risk of myocardial infarction

Hypoxia-inducible factor-1-dependent mechanisms of vascularization and vascular remodelling

The Effect of Pravastatin on Coronary Events after Myocardial Infarction in Patients with Average Cholesterol Levels

Outcome of patients with diabetes mellitus and acute myocardial infarction treated with thrombolytic agents

Angiographic progression of coronary artery disease and the development of myocardial infarction

Impaired collateral vessel development in diabetes: potential cellular mechanisms and therapeutic implications

Are we misunderstanding beta-blockers

Biochemistry and molecular cell biology of diabetic complications

Progress and challenges in translating the biology of atherosclerosis

A Meta-Analysis of 17 Randomized Trials of a Percutaneous Coronary Intervention-Based Strategy in Patients With Stable Coronary Artery Disease

Myocardial reperfusion: Is it ever too late?

Hemorrhagic potential of combined diltiazem and recombinant tissue-type plasminogen activator administration

The Pathogenesis of Coronary Artery Disease and the Acute Coronary Syndromes

Antithrombotic Therapy for Venous Thromboembolic Disease

Treatment and outcomes in patients with myocardial infarction treated with acute β-blocker therapy: Results from the American College of Cardiology’s NCDR®

Hemorrhagic Complications of Anticoagulant and Thrombolytic Treatment

Rescue Angioplasty after Failed Thrombolytic Therapy for Acute Myocardial Infarction

Oxygen Sensing, Homeostasis, and Disease

SHould We Emergently Revascularize Occluded Coronaries for Cardiogenic ShocK: An international randomized trial of emergency PTCA/CABG—trial design

Intensive versus Moderate Lipid Lowering with Statins after Acute Coronary Syndromes

The pathogenesis of atherosclerosis: a perspective for the 1990s

Effect of age on outcome with primary angioplasty versus thrombolysis

Triggering of Acute Myocardial Infarction by Heavy Physical Exertion -- Protection against Triggering by Regular Exertion

Range of serum cholesterol values in the population developing coronary artery disease

A multicenter disease management program for hospitalized patients with heart failure

An Association between Collateral Blood Flow and Myocardial Viability in Patients with Recent Myocardial Infarction

The PRISMA Statement for Reporting Systematic Reviews and Meta-Analyses of Studies That Evaluate Health Care Interventions: Explanation and Elaboration

Multidisciplinary strategies for the management of heart failure patients at high risk for admission

Regulation of Vascular Endothelial Growth Factor in Cardiac Myocytes

Randomized Comparison Between Stenting and Off-Pump Bypass Surgery in Patients Referred for Angioplasty

Guidelines for the Early Management of Patients With Acute Ischemic Stroke

Indications for fibrinolytic therapy in suspected acute myocardial infarction: collaborative overview of early mortality and major morbidity results from all randomised trials of more than 1000 patients

HIF-1α is required for development of the sympathetic nervous system

Validation of Intravascular Ultrasound–Derived Parameters With Fractional Flow Reserve for Assessment of Coronary Stenosis Severity

Vascular Responses to Hypoxia and Ischemia

AHA/ACCF Secondary Prevention and Risk Reduction Therapy for Patients With Coronary and Other Atherosclerotic Vascular Disease: 2011 Update

Abciximab Facilitates the Rate and Extent of Thrombolysis

Tissue Plasminogen Activator for Acute Ischemic Stroke

Physiology meets biophysics: Visualizing the interaction of hypoxia-inducible factor 1α with p300 and CBP

A Randomized Trial of Therapies for Type 2 Diabetes and Coronary Artery Disease

Biochemical purification and pharmacological inhibition of a mammalian prolyl hydroxylase acting on hypoxia-inducible factor

Abnormal monocyte recruitment and collateral artery formation in monocyte chemoattractant protein-1 deficient mice

Recommendations for Cardiovascular Screening, Staffing, and Emergency Policies at Health/Fitness Facilities

Comparison of Coronary Bypass Surgery with Angioplasty in Patients with Multivessel Disease

Acute Myocardial Infarction and Renal Dysfunction: A High-Risk Combination

Hypoxia-Inducible Factor 1 and Cardiovascular Disease

Percutaneous Coronary Intervention in the Current Era Compared With 1985–1986

Exercise Standards for Testing and Training

Acute stroke: evaluation and treatment.

Oxygen Sensing, Hypoxia-Inducible Factors, and Disease Pathophysiology

Effects of Prophylactic Antiarrhythmic Drug Therapy in Acute Myocardial Infarction

Danish Multicenter Randomized Study of Invasive Versus Conservative Treatment in Patients With Inducible Ischemia After Thrombolysis in Acute Myocardial Infarction (DANAMI)

Case management in a heterogeneous congestive heart failure population: a randomized controlled trial.

Negative regulation of hypoxia-inducible genes by the von Hippel-Lindau protein.

Trial Design and Reporting Standards for Intraarterial Cerebral Thrombolysis for Acute Ischemic Stroke

Structure of an HIF-1α-pVHL Complex: Hydroxyproline Recognition in Signaling

Hypoxia-inducible factor-1 modulates gene expression in solid tumors and influences both angiogenesis and tumor growth

Meta-analysis: Effects of Percutaneous Coronary Intervention Versus Medical Therapy on Angina Relief

Intravenous Alteplase for Stroke

Treatment of myocardial infarction in the United States (1990 to 1993). Observations from the National Registry of Myocardial Infarction.

Hemorrhagic Transformation in Acute Ischemic Stroke

ACC/AHA Clinical Performance Measures for Adults With ST-Elevation and Non–ST-Elevation Myocardial Infarction

Risks and Benefits of Estrogen Plus Progestin in Healthy Postmenopausal Women: Principal Results From the Women's Health Initiative Randomized Controlled Trial

ACC/AHA 2008 Performance Measures for Adults With ST-Elevation and Non–ST-Elevation Myocardial Infarction

Telephone follow-up, initiated by a hospital-based health professional, for postdischarge problems in patients discharged from hospital to home

High intensity aerobic interval exercise is superior to moderate intensity exercise for increasing aerobic capacity in patients with coronary artery disease

Age and Outcome With Contemporary Thrombolytic Therapy

Percutaneous Coronary Intervention Versus Conservative Therapy in Nonacute Coronary Artery Disease

Randomized Trial of Telephone Intervention in Chronic Heart Failure (DIAL): Study design and preliminary observations

Adenoviral transfer of HIF-1α enhances vascular responses to critical limb ischemia in diabetic mice

Early intravenous then oral metoprolol in 45 852 patients with acute myocardial infarction: randomised placebo-controlled trial

HIF-1 and human disease: one highly involved factor

2014 AHA/ACC Guideline for the Management of Patients With Non–ST-Elevation Acute Coronary Syndromes

AHA/ACCF Secondary Prevention and Risk Reduction Therapy for Patients With Coronary and Other Atherosclerotic Vascular Disease: 2011 Update

2011 ACCF/AHA Focused Update Incorporated Into the ACC/AHA 2007 Guidelines for the Management of Patients With Unstable Angina/Non–ST-Elevation Myocardial Infarction

Increased Carotid Artery Intimal-Medial Thickness in Asymptomatic Older Subjects With Exercise-Induced Myocardial Ischemia

2011 ACCF/AHA/SCAI Guideline for Percutaneous Coronary Intervention

Interindividual Heterogeneity in the Hypoxic Regulation of VEGF

Hypoxia-inducible factor 1 is required for remote ischemic preconditioning of the heart

Inhibition of the oxygen sensor PHD2 in the liver improves survival in lactic acidosis by activating the Cori cycle

Influence of Diabetes on 5-Year Mortality and Morbidity in a Randomized Trial Comparing CABG and PTCA in Patients With Multivessel Disease

ACC/AHA Guidelines for Percutaneous Coronary Intervention (Revision of the 1993 PTCA Guidelines)—Executive Summary

Coronary Thrombolysis for the Elderly?

Nifedipine

Guidelines for Thrombolytic Therapy for Acute Stroke: A Supplement to the Guidelines for the Management of Patients With Acute Ischemic Stroke

Meta-analysis: Effects of Percutaneous Coronary Intervention Versus Medical Therapy on Angina Relief

Sexual Activity and Cardiovascular Disease

2012 ACCF/AHA Focused Update Incorporated Into the ACCF/AHA 2007 Guidelines for the Management of Patients With Unstable Angina/Non–ST-Elevation Myocardial Infarction

Prognostic significance of nonfatal reinfarction during 3-year follow-up: Results of the thrombolysis in myocardial infarction (TIMI) phase II clinical trial

Modifiers of timing and possible triggers of acute myocardial infarction in the thrombolysis in myocardial infarction phase II (TIMI II) study group

Effects of acute hormone therapy on recurrent ischemia in postmenopausal women with unstable angina

Prognostic value of N-terminal proatrial natriuretic factor plasma levels measured within the first 12 hours after myocardial infarction

L-Arginine Therapy in Acute Myocardial Infarction

Risk stratification before thrombolytic therapy in patients with acute myocardial infarction

Six- and twelve-month follow-up of the phase I thrombolysis in myocardial infarction (TIMI) trial

Coronary angioplasty after recombinant tissue-type plasminogen activator in acute myocardial infarction: A report from the thrombolysis in myocardial infarction (TIMI) trial

Relation Between Clinical, Angiographic and Ischemic Findings at Baseline and Ischemia-Related Adverse Outcomes at 1 Year in the Asymptomatic Cardiac Ischemia Pilot Study fn1fn1This study was funded by the National Heart, Lung, and Blood Institute, Cardiac Diseases Branch, Division of Heart and Vascular Diseases, National Institutes of Health, Bethesda, Maryland, by Research Contracts HV-90-07, HV90-08, HV-91-05 to HV-91-14. Study medications and placebo were donated by Zeneca Pharmaceuticals Group, Wilmington, Delaware; Marion-Merrell Dow, Kansas City, Missouri; and Pfizer, New York, New York. Support for electrocardiographic data collection was provided in part by Applied Cardiac Systems, Laguna Hills, California; Marquette Electronics, Milwaukee, Wisconsin; Mortara Instrument, Milwaukee, Wisconsin; and Quinton Instruments, Seattle, Washington. Some centers had partial support from grants from the General Clinical Research Center, National Institutes of Health.

Asymptomatic cardiac ischemia pilot (ACIP) study: Outcome at 1 year for patients with asymptomatic cardiac ischemia randomized to medical therapy or revascularization

Clinical features and pathogenesis of intracerebral hemorrhage after rt-PA and heparin therapy for acute myocardial infarction

The thrombolysis in myocardial infarction (TIMI) phase II pilot study: Tissue plasminogen activator followed by percutaneous transluminal coronary angioplasty

A randomized trial of the efficacy of multidisciplinary care in heart failure outpatients at high risk of hospital readmission

Value of radionuclide rest and exercise left ventricular ejection fraction in assessing survival of patients after thrombolytic therapy for acute myocardial infarction: Results of thrombolysis in myocardial infarction (TIMI) phase II study

Factors Influencing Clinical Outcomes After Revascularization in the Asymptomatic Cardiac Ischemia Pilot (ACIP)

Value of rescue percutaneous transluminal coronary angioplasty following unsuccessful thrombolytic therapy in patients with acute myocardial infarction

Asymptomatic Cardiac Ischemia Pilot (ACIP) Study

Two- and three-year results of the thrombolysis in myocardial infraction (TIMI) phaes II clinical trial

The natural history of coronary heart disease: prognostic factors after recovery from myocardial infarction in 2789 men. The 5-year findings of the coronary drug project.

Long-Term Effects on Clinical Outcomes of Aggressive Lowering of Low-Density Lipoprotein Cholesterol Levels and Low-Dose Anticoagulation in the Post Coronary Artery Bypass Graft Trial

Ischemic Cerebral Infarction After rt-PA and Heparin Therapy for Acute Myocardial Infarction

Influence of coronary collateral vessels on myocardial infarct size in humans. Results of phase I thrombolysis in myocardial infarction (TIMI) trial. The TIMI Investigators.

Left Ventricular, Peripheral Vascular, and Neurohumoral Responses to Mental Stress in Normal Middle-Aged Men and Women

Aggressive Cholesterol Lowering Delays Saphenous Vein Graft Atherosclerosis in Women, the Elderly, and Patients With Associated Risk Factors

Diabetics With Coronary Disease Have a Prevalence of Asymptomatic Ischemia During Exercise Treadmill Testing and Ambulatory Ischemia Monitoring Similar to That of Nondiabetic Patients

Predictors of early morbidity and mortality after thrombolytic therapy of acute myocardial infarction. Analyses of patient subgroups in the Thrombolysis in Myocardial Infarction (TIMI) trial, phase II.

Immediate versus deferred beta-blockade following thrombolytic therapy in patients with acute myocardial infarction. Results of the Thrombolysis in Myocardial Infarction (TIMI) II-B Study.

Intracerebral hemorrhage, cerebral infarction, and subdural hematoma after acute myocardial infarction and thrombolytic therapy in the Thrombolysis in Myocardial Infarction Study. Thrombolysis in Myocardial Infarction, Phase II, pilot and clinical trial.

Asymptomatic Cardiac Ischemia Pilot (ACIP) Study Two-Year Follow-up

Thrombolysis in myocardial infarction (TIMI): Comparative studies of coronary reperfusion and systemic fibrinogenolysis with two forms of recombinant tissue-type plasminogen activator